M&T Bank
KRYS icon

M&T Bank’s Krystal Biotech KRYS Stock Holding History

M&T Bank’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
+668
New +$200K ﹤0.01% 1555
2025
Q3 		– Sell
-3,785
Closed -$520K – 1553
2025
Q2 		$520K Buy
3,785
+85
+2% +$12.5K ﹤0.01% 1061
2025
Q1 		$667K Buy
+3,700
New +$622K ﹤0.01% 960

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

M&T Bank's KRYS Position: Q2 2026 in Review

M&T Bank opened a new position in Krystal Biotech (KRYS) in Q2 2026: 668 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #1555 among its holdings. This is a return to the name: M&T Bank previously reported a position in KRYS as recently as Q2 2025.

M&T Bank first reported a position in KRYS in Q1 2025 and has held it in 3 quarters since. The position peaked at $667K in Q1 2025. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • M&T Bank held 668 shares of Krystal Biotech worth $248K as of Q2 2026.
  • Krystal Biotech was a new M&T Bank position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1555 holding.
  • M&T Bank first reported a position in Krystal Biotech in Q1 2025 and has held it in 3 quarters since.
  • M&T Bank's Krystal Biotech position peaked at $667K in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.